Moberg Derma acquires US-based Alterna
Swedish pharmaceutical company Moberg Derma has agreed to acquire its US distributor Alterna LLC in a reverse triangular merger to establish its own market presence in the US. The upfront merger consideration will consist of both cash and newly issued Moberg Derma shares through an issue in kind, as well as potential additional consideration based on future revenue. The transaction also involves a directed share issue to certain institutional investors in Sweden, as well as external acquisition financing.
Alterna LLC is a US company with both over-the-counter and self-care products within dermatology and topical pain treatment, including the Kerasal® and JointFlex® brands.
Moberg Derma develops and commercializes patented medical devices for the treatment of common diseases, including through innovative drug delivery solutions. The company’s share is listed on the NASDAQ OMX Nordic Exchange Stockholm.
Moberg Derma was advised by Mannheimer Swartling in the transaction. The firm’s team was led by Isabella Ramsay (M&A) and Eva Hägg (Public M&A and ECM), primarily assisted by Hampus Thofte (project manager), Marcus Glimberg, Gustaf Hygrell and Fredrik Livendahl. Daniel Karlsson was responsible for acquisition financing and Martin Nilsson for tax.